4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-123377
Director sold 500 shares at an average $57.90 ($28,952)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Petersen Floyd F. Director | 2023-12-01 | Sale 10b5-1 | −135 | $57.24 | $7,727 | 81,698 | D |
| Petersen Floyd F. Director | 2023-12-01 | Sale 10b5-1 | −365 | $58.15 | $21,225 | 81,333 | D |
| Open-market sales · 500 sh · avg $57.90 · $28,952 | |||||||
Loading xslF345X05/tm2332102-1_4seq1.xml…